Abstract:Extracellular matrix-degrading matrix metalloproteinase-1 (MMP-1) is one of the interstitial collagenases likely to be involved in tumor invasion and metastasis. MMP-1 may also contribute to tumor initiation and development by altering the cellular microenvironment that facilitates tumor formation. Recent studies have found that overexpression of MMP-1 is associated with the initial stages of cancer development in addition to promoting cellular invasion; however, preexisting oncogenic mutations or chemical carcinogens are required to initiate tumorigenesis as well. There is a single nucleotide polymorphism located in the promoter region of MMP-1 that partially regulates gene expression. The 2G/2G genotype enhances transcriptional activity and may be associated with an increased lung cancer risk. Using a case-control study, we tested the hypotheses that (a) individuals with the 2G/2G genotype may be at an increased risk for lung cancer; and (b) the risk should be greatly elevated in smoking individuals. PCR-RFLP was used to determine the MMP-1 genotypes in 456 lung-cancer cases and 451 frequency-matched controls of Caucasian ethnicity. Overall, there was a significant association between the 2G/2G genotype and lung cancer risk [odds ratio (OR), 1.76; 95% confidence interval (CI), 1.29-2.39]. In current smokers, the lung cancer risk associated with the 2G/2G genotype was significantly elevated (OR, 3.16; 95% CI, 1.87-5.35). However, this association was less evident in former smokers (OR, 1.23; 95% CI, 0.81-1.87) and absent in never smokers (OR, 1.09; 95% CI, 0.31-3.91). Similarly, this risk was more evident in heavy smokers (OR, 2.55; 95% CI, 1.61-4.03) than in light smokers (OR, 1.40; 95% CI, 0.84-2.32). Interestingly, men were observed to have a 2.15-fold increased lung cancer risk (OR, 2.15; 95% CI, 1.42-3.26) compared with women (OR, 1.34; 95% CI, 0.84-2.15). Furthermore, subjects with 2G/2G genotype developed lung cancer earlier (60.94 +/- 0.64 years old) than patients with 1G/1G and 1G/2G genotypes (62.91 +/- 0.59 years old; P = 0.024). Our data demonstrate that the 2G/2G genotype enhances lung cancer susceptibility especially in current smokers. To our knowledge, these results report the first molecular epidemiological evidence of the MMP-1 promoter polymorphism associated with the development of lung cancer in the presence of continuing carcinogenic exposure.

Genetic Variants in the MDM2 Promoter and Lung Cancer Risk in a Chinese Population.

SNP Rs17079281 Decreases Lung Cancer Risk Through Creating an YY1-Binding Site to Suppress DCBLD1 Expression

MDM2 309 T/G polymorphism is associated with lung cancer risk among Asians.

The Mdm2 T309g Polymorphism And Risk Of Lung Cancer: An Updated Meta-Analysis Of 10,186 Cases And 14,155 Controls

Association of MDM2 Promoter T309G Polymorphism with Oral Cancer Risk: A Meta-Analysis of 3,536 Subjects

MDM2 SNP309T>G Polymorphism with Hepatocellular Carcinoma Risk: A Meta-analysis

A Novel Functional Polymorphism C1797g In The Mdm2 Promoter Is Associated With Risk Of Bladder Cancer In A Chinese Population

Methyl-Cpg Binding Domain 1 Gene Polymorphisms and Lung Cancer Risk in A Chinese Population

Genetic Variants in Mgmt and Risk of Lung Cancer in Southeastern Chinese: A Haplotype Based Analysis

Association of Matrix Metalloproteinase‐2 and ‐9 Promoter Polymorphisms with Colorectal Cancer in Chinese

Correlation Between A Single Nucleotide Polymorphism In The Matrix Metalloproteinase-2 Promoter And Risk Of Lung Cancer

Candidate Variants at 6p21.33 and 6p22.1 and Risk of Non-Small Cell Lung Cancer in a Chinese Population.

A Single Nucleotide Polymorphism in the Matrix Metalloproteinase-2 Promoter is Associated with Colorectal Cancer.

MDM2 SNP309T>G polymorphism increases susceptibility to hepatitis B virus-related hepatocellular carcinoma in a northeast Han Chinese population

MDM2 Promoter SNP309 is Associated with an Increased Susceptibility to Chronic Lymphocytic Leukemia and Correlates with MDM2 Mrna Expression in Chinese Patients with CLL

Polymorphisms in DNA damage binding protein 2 (DDB2) and susceptibility of primary lung cancer in the Chinese: a case-control study.

No Association Between the Polymorphisms in Matrix Metalloproteinase-1 and Matrix Metalloproteinase-3 Promoter Regions and Colorectal Cancer in Chinese

MDM2 309 T/G polymorphism is associated with colorectal cancer risk especially in Asians: a meta-analysis

Association between single nucleotide polymorphisms in MDM2 and the susceptibility of hepatocellular carcinoma(HCC)

Mdm2 Promoter Snp309 Is Associated With Risk Of Occurrence And Advanced Lymph Node Metastasis Of Nasopharyngeal Carcinoma In Chinese Population

A Single Nucleotide Polymorphism in the Matrix Metalloproteinase-1 Promoter Enhances Lung Cancer Susceptibility.